Open AccessRepeated intravitreal injections of antivascular endothelial growth factors and risk of intraocular pressure medication use
Author(s) -
Qi N. Cui,
Iga N Gray,
Yinxi Yu,
Brian L. VanderBeek
Publication year - 2019
Publication title -
graefe's archive for clinical and experimental ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.196
H-Index - 101
eISSN - 1435-702X
pISSN - 0721-832X
DOI - 10.1007/s00417-019-04362-7
Subject(s) - medicine , glaucoma , intraocular pressure , quartile , odds ratio , glaucoma medication , logistic regression , population , ocular hypertension , ophthalmology , retrospective cohort study , confidence interval , environmental health
To determine the risk of initiating ocular hypertension and glaucoma treatment with repeated injections of antivascular endothelial growth factors (anti-VEGF).